OpenURL Connection Search

Select item for more details and to access through your institution.

Predictors of withdrawal from renal replacement therapy among patients with acute kidney injury requiring renal replacement therapy.
Published in:
Clinical & Experimental Nephrology, 2019, v. 23, n. 6, p. 814, doi. 10.1007/s10157-019-01711-y
By:
- Ihara, Katsuhito;
- Ishigami, Junichi;
- Inoshita, Seiji
Publication type:
Article
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.
Published in:
Science Translational Medicine, 2022, v. 14, n. 657, p. 1, doi. 10.1126/scitranslmed.abj2109
By:
- Kobayashi, Hiroki;
- Looker, Helen C.;
- Satake, Eiichiro;
- D'Addio, Francesca;
- Wilson, Jonathan M.;
- Saulnier, Pierre Jean;
- Md Dom, Zaipul I.;
- O'Neil, Kristina;
- Ihara, Katsuhito;
- Krolewski, Bozena;
- Badger, Hannah S.;
- Petrazzuolo, Adriana;
- Corradi, Domenico;
- Galecki, Andrzej;
- Wilson, Parker C.;
- Najafian, Behzad;
- Mauer, Michael;
- Niewczas, Monika A.;
- Doria, Alessandro;
- Humphreys, Benjamin D.
Publication type:
Article
Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes.
Published in:
Science Translational Medicine, 2021, v. 13, n. 600, p. 1, doi. 10.1126/scitranslmed.abd2699
By:
- Md Dom, Zaipul I.;
- Satake, Eiichiro;
- Skupien, Jan;
- Krolewski, Bozena;
- O'Neil, Kristina;
- Willency, Jill A.;
- Dillon, Simon T.;
- Wilson, Jonathan M.;
- Kobayashi, Hiroki;
- Ihara, Katsuhito;
- Libermann, Towia A.;
- Pragnell, Marlon;
- Duffin, Kevin L.;
- Krolewski, Andrzej S.
Publication type:
Article
Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43:2760-2767.
Published in:
2021
By:
- Ihara, Katsuhito;
- Skupien, Jan;
- Kobayashi, Hiroki;
- Md Dom, Zaipul I.;
- Wilson, Jonathan M.;
- O'Neil, Kristina;
- Badger, Hannah S.;
- Bowsman, Lenden M.;
- Satake, Eiichiro;
- Breyer, Matthew D.;
- Duffin, Kevin L.;
- Krolewski, Andrzej S.
Publication type:
journal article
Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.
Published in:
2020
By:
- Ihara, Katsuhito;
- Skupien, Jan;
- Kobayashi, Hiroki;
- Md Dom, Zaipul I.;
- Wilson, Jonathan M.;
- O'Neil, Kristina;
- Badger, Hannah S.;
- Bowsman, Lenden M.;
- Satake, Eiichiro;
- Breyer, Matthew D.;
- Duffin, Kevin L.;
- Krolewski, Andrzej S.
Publication type:
journal article
525-P: Integrated Mirnome and Proteomic Analyses in Plasma and Progression to ESRD in Diabetes.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-525-P
By:
- SATAKE, EIICHIRO;
- SKUPIEN, JAN;
- MD DOM, ZAIPUL I.;
- KOBAYASHI, HIROKI;
- IHARA, KATSUHITO;
- PEZZOLESI, MARCUS G.;
- NIEWCZAS, MONIKA;
- KROLEWSKI, ANDRZEJ
Publication type:
Article

Found: 6

Predictors of withdrawal from renal replacement therapy among patients with acute kidney injury requiring renal replacement therapy.

Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes.

Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43:2760-2767.

Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.

525-P: Integrated Mirnome and Proteomic Analyses in Plasma and Progression to ESRD in Diabetes.